These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 29290076)

  • 21. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Certolizumab pegol for treating axial spondyloarthritis.
    Desmarais J; Beier S; Deodhar A
    Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
    Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of TNF-α Inhibitors in the Treatment of nr-axSpA: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
    Shentu H; Sha S; He Y; He M; Dong N; Huang Z; Lai H; Chen M; Huang J; Huang X
    Int Arch Allergy Immunol; 2024; 185(6):590-599. PubMed ID: 38432201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis.
    Paccou J; Flipo RM
    Drug Des Devel Ther; 2016; 10():2255-62. PubMed ID: 27468228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Vorbrüggen W; Welcker M
    Rheumatol Int; 2024 Apr; 44(4):653-661. PubMed ID: 37805981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
    Keat A; Bennett AN; Gaffney K; Marzo-Ortega H; Sengupta R; Everiss T
    Rheumatol Int; 2017 Mar; 37(3):327-336. PubMed ID: 28035438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
    Sieper J; Rudwaleit M; Lenaerts J; Wollenhaupt J; Myasoutova L; Park SH; Song YW; Yao R; Huyck S; Govoni M; Chitkara D; Vastesaeger N
    Rheumatology (Oxford); 2016 Nov; 55(11):1946-1953. PubMed ID: 27411482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
    Braun J; Kiltz U; Baraliakos X
    Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.
    Braun J; Baraliakos X; Heldmann F; Kiltz U
    Expert Opin Investig Drugs; 2014 May; 23(5):647-59. PubMed ID: 24654630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.
    López-Medina C; Ramiro S; van der Heijde D; Sieper J; Dougados M; Molto A
    RMD Open; 2019; 5(2):e001108. PubMed ID: 31803500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
    Rodrigues-Manica S; Silva J; Cruz-Machado R; Coelho C; Duarte J; Vieira-Sousa E; Tavares-Costa J; Pimentel-Santos FM
    Clin Rheumatol; 2021 Jan; 40(1):33-41. PubMed ID: 32533340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
    Fukui S; Kawaai S; Sawada H; Kishimoto M
    Expert Rev Clin Immunol; 2024 Feb; 20(2):141-153. PubMed ID: 37955181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
    Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
    Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Certolizumab pegol in axial spondyloarthritis.
    Song IH; Rudwaleit M
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1161-72. PubMed ID: 24215406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol.
    Dalix E; Marcelli C; Bejan-Angoulvant T; Finckh A; Rancon F; Akrour M; De Araujo L; Presles E; Marotte H;
    BMJ Open; 2024 Sep; 14(9):e087872. PubMed ID: 39260856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.
    Sieper J; Hu X; Black CM; Grootscholten K; van den Broek RWM; Kachroo S
    Semin Arthritis Rheum; 2017 Jun; 46(6):746-753. PubMed ID: 27855973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.